← Consumer Healthcare Products Association
FDANonrulemakingFDA-2025-D-1504

Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability

RIN
—
Last modified
Jun 29, 2026
Comment window
closed 81d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between May 8, 2026 and May 8, 2026. 4 other organizations filed here. The comment window closed 81d ago.

What Consumer Healthcare Products Association filed (1)

May 8, 2026· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2025-D-1504-0035

CHPA Comments: Responding to FDA Form 483 Observations at the Conclusion of a Drug cGMP Inspection: Draft Guidance for Industry

Download attachment ↓View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (4)

See everyone who commented →
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability (FDA) — Consumer Healthcare Products Association | OpenPolis